Citrullination at the N‐terminal region of MDM2 by the PADI4 enzyme
PADI4 is one of the human isoforms of a family of enzymes involved in the conversion of arginine to citrulline. MDM2 is an E3 ubiquitin ligase that is critical for degradation of the tumor suppressor gene p53. We have previously shown that there is an interaction between MDM2 and PADI4 in cellulo, a...
Gespeichert in:
Veröffentlicht in: | Protein science 2025-02, Vol.34 (2), p.e70033-n/a |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | n/a |
---|---|
container_issue | 2 |
container_start_page | e70033 |
container_title | Protein science |
container_volume | 34 |
creator | Neira, José L. Rizzuti, Bruno Palomino‐Schätzlein, Martina Rejas, Virginia Abian, Olga Velazquez‐Campoy, Adrian |
description | PADI4 is one of the human isoforms of a family of enzymes involved in the conversion of arginine to citrulline. MDM2 is an E3 ubiquitin ligase that is critical for degradation of the tumor suppressor gene p53. We have previously shown that there is an interaction between MDM2 and PADI4 in cellulo, and that such interaction occurs through the N‐terminal region of MDM2, N‐MDM2, and in particular through residues Thr26, Val28, Phe91, and Lys98. Here, by using a “divide‐and‐conquer” approach, we have designed and synthesized peptides comprising these two polypeptide stretches (residues Ala21–Lys36, and Lys94–Val108), either in the wild‐type species or in their citrullinated versions. Some of the citrullinated peptides were aggregation‐prone, as suggested by DOSY‐NMR experiments, but the wild‐type versions of both fragments were monomeric in solution. We found out that wild‐type and modified peptides were disordered in all cases, as also tested by far‐UV circular dichroism (CD), and citrullination mainly affected the NMR chemical shifts of adjacent residues. Isothermal titration calorimetry (ITC) in the absence and presence of GSK484, an enzymatic PADI4 inhibitor, indicated that this compound blocked binding of the peptides to the enzyme. Binding to the active site of the N‐MDM2 fragments was also confirmed by in silico experiments. The affinities of PADI4 for the wild‐type peptides were more favorable than those of the corresponding citrullinated ones, but all measured values were within the micromolar range, indicating that there were no major variations in the thermodynamics of binding due to sequence effects. The kinetic dissociation rates, koff, measured by biolayer interferometry (BLI), were always one‐order of magnitude faster for the citrullinated peptides than for the wild‐type ones. Taken together, all these findings indicate that MDM2 is a substrate for PADI4 and is prone to citrullination in the identified (and specific) positions of its N‐terminal region. |
doi_str_mv | 10.1002/pro.70033 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3158102990</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3158102990</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2433-10f411a6b9b6074abc67d0558d8339f4b317325665dc21c09d2f28456c3356563</originalsourceid><addsrcrecordid>eNp10MtKw0AYBeBBFFurC19AAm50kfafazJLaasWWltEwV3IZaIpSVNnEiSufASf0Sdx2lQXgqthZj4OnIPQKYY-BiCDtS77HgCle6iLmZCuL8XTPuqCFNj1qfA76MiYJQAwTOgh6lDpM_AxdNF4mFW6zvNsFVZZuXLCyqlelHP39fFZKV3Y59zR6nnzVabObDQjTtRsyeJqNGGOWr03hTpGB2mYG3WyO3vo8Xr8MLx1p_ObyfBq6saEUepiSBnGoYhkJMBjYRQLLwHO_cSnVKYsotijhAvBk5jgGGRCUuIzLmJKueCC9tBFm2sbv9bKVEGRmVjlebhSZW0CirltRaQES8__0GVZa1tnowQB6UlOrbpsVaxLY7RKg7XOilA3AYZgs629l8F2W2vPdol1VKjkV_6MacGgBW9Zrpr_k4LF_byN_AYg1X_D</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3162097953</pqid></control><display><type>article</type><title>Citrullination at the N‐terminal region of MDM2 by the PADI4 enzyme</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Neira, José L. ; Rizzuti, Bruno ; Palomino‐Schätzlein, Martina ; Rejas, Virginia ; Abian, Olga ; Velazquez‐Campoy, Adrian</creator><creatorcontrib>Neira, José L. ; Rizzuti, Bruno ; Palomino‐Schätzlein, Martina ; Rejas, Virginia ; Abian, Olga ; Velazquez‐Campoy, Adrian</creatorcontrib><description>PADI4 is one of the human isoforms of a family of enzymes involved in the conversion of arginine to citrulline. MDM2 is an E3 ubiquitin ligase that is critical for degradation of the tumor suppressor gene p53. We have previously shown that there is an interaction between MDM2 and PADI4 in cellulo, and that such interaction occurs through the N‐terminal region of MDM2, N‐MDM2, and in particular through residues Thr26, Val28, Phe91, and Lys98. Here, by using a “divide‐and‐conquer” approach, we have designed and synthesized peptides comprising these two polypeptide stretches (residues Ala21–Lys36, and Lys94–Val108), either in the wild‐type species or in their citrullinated versions. Some of the citrullinated peptides were aggregation‐prone, as suggested by DOSY‐NMR experiments, but the wild‐type versions of both fragments were monomeric in solution. We found out that wild‐type and modified peptides were disordered in all cases, as also tested by far‐UV circular dichroism (CD), and citrullination mainly affected the NMR chemical shifts of adjacent residues. Isothermal titration calorimetry (ITC) in the absence and presence of GSK484, an enzymatic PADI4 inhibitor, indicated that this compound blocked binding of the peptides to the enzyme. Binding to the active site of the N‐MDM2 fragments was also confirmed by in silico experiments. The affinities of PADI4 for the wild‐type peptides were more favorable than those of the corresponding citrullinated ones, but all measured values were within the micromolar range, indicating that there were no major variations in the thermodynamics of binding due to sequence effects. The kinetic dissociation rates, koff, measured by biolayer interferometry (BLI), were always one‐order of magnitude faster for the citrullinated peptides than for the wild‐type ones. Taken together, all these findings indicate that MDM2 is a substrate for PADI4 and is prone to citrullination in the identified (and specific) positions of its N‐terminal region.</description><identifier>ISSN: 0961-8368</identifier><identifier>ISSN: 1469-896X</identifier><identifier>EISSN: 1469-896X</identifier><identifier>DOI: 10.1002/pro.70033</identifier><identifier>PMID: 39840810</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Binding ; Calorimetry ; Circular dichroism ; Citrullination ; Citrulline ; Dichroism ; Enzymes ; Fragments ; Humans ; Interferometry ; Isoforms ; isothermal titration calorimetry ; MDM2 ; MDM2 protein ; molecular docking ; NMR ; Nuclear magnetic resonance ; p53 Protein ; PADI4 ; Peptides ; Peptides - chemistry ; Peptides - metabolism ; Polypeptides ; Protein Binding ; Protein-arginine deiminase ; Protein-Arginine Deiminase Type 4 - chemistry ; Protein-Arginine Deiminase Type 4 - metabolism ; Protein-Arginine Deiminases - chemistry ; Protein-Arginine Deiminases - genetics ; Protein-Arginine Deiminases - metabolism ; protein–protein interactions ; Proto-Oncogene Proteins c-mdm2 - chemistry ; Proto-Oncogene Proteins c-mdm2 - genetics ; Proto-Oncogene Proteins c-mdm2 - metabolism ; Residues ; Titration ; Titration calorimetry ; Tumor suppressor genes ; Ubiquitin-protein ligase</subject><ispartof>Protein science, 2025-02, Vol.34 (2), p.e70033-n/a</ispartof><rights>2025 The Protein Society.</rights><rights>2025 The Protein Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2433-10f411a6b9b6074abc67d0558d8339f4b317325665dc21c09d2f28456c3356563</cites><orcidid>0000-0001-5702-4538 ; 0000-0002-4933-0428</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpro.70033$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpro.70033$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39840810$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Neira, José L.</creatorcontrib><creatorcontrib>Rizzuti, Bruno</creatorcontrib><creatorcontrib>Palomino‐Schätzlein, Martina</creatorcontrib><creatorcontrib>Rejas, Virginia</creatorcontrib><creatorcontrib>Abian, Olga</creatorcontrib><creatorcontrib>Velazquez‐Campoy, Adrian</creatorcontrib><title>Citrullination at the N‐terminal region of MDM2 by the PADI4 enzyme</title><title>Protein science</title><addtitle>Protein Sci</addtitle><description>PADI4 is one of the human isoforms of a family of enzymes involved in the conversion of arginine to citrulline. MDM2 is an E3 ubiquitin ligase that is critical for degradation of the tumor suppressor gene p53. We have previously shown that there is an interaction between MDM2 and PADI4 in cellulo, and that such interaction occurs through the N‐terminal region of MDM2, N‐MDM2, and in particular through residues Thr26, Val28, Phe91, and Lys98. Here, by using a “divide‐and‐conquer” approach, we have designed and synthesized peptides comprising these two polypeptide stretches (residues Ala21–Lys36, and Lys94–Val108), either in the wild‐type species or in their citrullinated versions. Some of the citrullinated peptides were aggregation‐prone, as suggested by DOSY‐NMR experiments, but the wild‐type versions of both fragments were monomeric in solution. We found out that wild‐type and modified peptides were disordered in all cases, as also tested by far‐UV circular dichroism (CD), and citrullination mainly affected the NMR chemical shifts of adjacent residues. Isothermal titration calorimetry (ITC) in the absence and presence of GSK484, an enzymatic PADI4 inhibitor, indicated that this compound blocked binding of the peptides to the enzyme. Binding to the active site of the N‐MDM2 fragments was also confirmed by in silico experiments. The affinities of PADI4 for the wild‐type peptides were more favorable than those of the corresponding citrullinated ones, but all measured values were within the micromolar range, indicating that there were no major variations in the thermodynamics of binding due to sequence effects. The kinetic dissociation rates, koff, measured by biolayer interferometry (BLI), were always one‐order of magnitude faster for the citrullinated peptides than for the wild‐type ones. Taken together, all these findings indicate that MDM2 is a substrate for PADI4 and is prone to citrullination in the identified (and specific) positions of its N‐terminal region.</description><subject>Binding</subject><subject>Calorimetry</subject><subject>Circular dichroism</subject><subject>Citrullination</subject><subject>Citrulline</subject><subject>Dichroism</subject><subject>Enzymes</subject><subject>Fragments</subject><subject>Humans</subject><subject>Interferometry</subject><subject>Isoforms</subject><subject>isothermal titration calorimetry</subject><subject>MDM2</subject><subject>MDM2 protein</subject><subject>molecular docking</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>p53 Protein</subject><subject>PADI4</subject><subject>Peptides</subject><subject>Peptides - chemistry</subject><subject>Peptides - metabolism</subject><subject>Polypeptides</subject><subject>Protein Binding</subject><subject>Protein-arginine deiminase</subject><subject>Protein-Arginine Deiminase Type 4 - chemistry</subject><subject>Protein-Arginine Deiminase Type 4 - metabolism</subject><subject>Protein-Arginine Deiminases - chemistry</subject><subject>Protein-Arginine Deiminases - genetics</subject><subject>Protein-Arginine Deiminases - metabolism</subject><subject>protein–protein interactions</subject><subject>Proto-Oncogene Proteins c-mdm2 - chemistry</subject><subject>Proto-Oncogene Proteins c-mdm2 - genetics</subject><subject>Proto-Oncogene Proteins c-mdm2 - metabolism</subject><subject>Residues</subject><subject>Titration</subject><subject>Titration calorimetry</subject><subject>Tumor suppressor genes</subject><subject>Ubiquitin-protein ligase</subject><issn>0961-8368</issn><issn>1469-896X</issn><issn>1469-896X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10MtKw0AYBeBBFFurC19AAm50kfafazJLaasWWltEwV3IZaIpSVNnEiSufASf0Sdx2lQXgqthZj4OnIPQKYY-BiCDtS77HgCle6iLmZCuL8XTPuqCFNj1qfA76MiYJQAwTOgh6lDpM_AxdNF4mFW6zvNsFVZZuXLCyqlelHP39fFZKV3Y59zR6nnzVabObDQjTtRsyeJqNGGOWr03hTpGB2mYG3WyO3vo8Xr8MLx1p_ObyfBq6saEUepiSBnGoYhkJMBjYRQLLwHO_cSnVKYsotijhAvBk5jgGGRCUuIzLmJKueCC9tBFm2sbv9bKVEGRmVjlebhSZW0CirltRaQES8__0GVZa1tnowQB6UlOrbpsVaxLY7RKg7XOilA3AYZgs629l8F2W2vPdol1VKjkV_6MacGgBW9Zrpr_k4LF_byN_AYg1X_D</recordid><startdate>202502</startdate><enddate>202502</enddate><creator>Neira, José L.</creator><creator>Rizzuti, Bruno</creator><creator>Palomino‐Schätzlein, Martina</creator><creator>Rejas, Virginia</creator><creator>Abian, Olga</creator><creator>Velazquez‐Campoy, Adrian</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7T5</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5702-4538</orcidid><orcidid>https://orcid.org/0000-0002-4933-0428</orcidid></search><sort><creationdate>202502</creationdate><title>Citrullination at the N‐terminal region of MDM2 by the PADI4 enzyme</title><author>Neira, José L. ; Rizzuti, Bruno ; Palomino‐Schätzlein, Martina ; Rejas, Virginia ; Abian, Olga ; Velazquez‐Campoy, Adrian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2433-10f411a6b9b6074abc67d0558d8339f4b317325665dc21c09d2f28456c3356563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Binding</topic><topic>Calorimetry</topic><topic>Circular dichroism</topic><topic>Citrullination</topic><topic>Citrulline</topic><topic>Dichroism</topic><topic>Enzymes</topic><topic>Fragments</topic><topic>Humans</topic><topic>Interferometry</topic><topic>Isoforms</topic><topic>isothermal titration calorimetry</topic><topic>MDM2</topic><topic>MDM2 protein</topic><topic>molecular docking</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>p53 Protein</topic><topic>PADI4</topic><topic>Peptides</topic><topic>Peptides - chemistry</topic><topic>Peptides - metabolism</topic><topic>Polypeptides</topic><topic>Protein Binding</topic><topic>Protein-arginine deiminase</topic><topic>Protein-Arginine Deiminase Type 4 - chemistry</topic><topic>Protein-Arginine Deiminase Type 4 - metabolism</topic><topic>Protein-Arginine Deiminases - chemistry</topic><topic>Protein-Arginine Deiminases - genetics</topic><topic>Protein-Arginine Deiminases - metabolism</topic><topic>protein–protein interactions</topic><topic>Proto-Oncogene Proteins c-mdm2 - chemistry</topic><topic>Proto-Oncogene Proteins c-mdm2 - genetics</topic><topic>Proto-Oncogene Proteins c-mdm2 - metabolism</topic><topic>Residues</topic><topic>Titration</topic><topic>Titration calorimetry</topic><topic>Tumor suppressor genes</topic><topic>Ubiquitin-protein ligase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Neira, José L.</creatorcontrib><creatorcontrib>Rizzuti, Bruno</creatorcontrib><creatorcontrib>Palomino‐Schätzlein, Martina</creatorcontrib><creatorcontrib>Rejas, Virginia</creatorcontrib><creatorcontrib>Abian, Olga</creatorcontrib><creatorcontrib>Velazquez‐Campoy, Adrian</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Protein science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Neira, José L.</au><au>Rizzuti, Bruno</au><au>Palomino‐Schätzlein, Martina</au><au>Rejas, Virginia</au><au>Abian, Olga</au><au>Velazquez‐Campoy, Adrian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Citrullination at the N‐terminal region of MDM2 by the PADI4 enzyme</atitle><jtitle>Protein science</jtitle><addtitle>Protein Sci</addtitle><date>2025-02</date><risdate>2025</risdate><volume>34</volume><issue>2</issue><spage>e70033</spage><epage>n/a</epage><pages>e70033-n/a</pages><issn>0961-8368</issn><issn>1469-896X</issn><eissn>1469-896X</eissn><abstract>PADI4 is one of the human isoforms of a family of enzymes involved in the conversion of arginine to citrulline. MDM2 is an E3 ubiquitin ligase that is critical for degradation of the tumor suppressor gene p53. We have previously shown that there is an interaction between MDM2 and PADI4 in cellulo, and that such interaction occurs through the N‐terminal region of MDM2, N‐MDM2, and in particular through residues Thr26, Val28, Phe91, and Lys98. Here, by using a “divide‐and‐conquer” approach, we have designed and synthesized peptides comprising these two polypeptide stretches (residues Ala21–Lys36, and Lys94–Val108), either in the wild‐type species or in their citrullinated versions. Some of the citrullinated peptides were aggregation‐prone, as suggested by DOSY‐NMR experiments, but the wild‐type versions of both fragments were monomeric in solution. We found out that wild‐type and modified peptides were disordered in all cases, as also tested by far‐UV circular dichroism (CD), and citrullination mainly affected the NMR chemical shifts of adjacent residues. Isothermal titration calorimetry (ITC) in the absence and presence of GSK484, an enzymatic PADI4 inhibitor, indicated that this compound blocked binding of the peptides to the enzyme. Binding to the active site of the N‐MDM2 fragments was also confirmed by in silico experiments. The affinities of PADI4 for the wild‐type peptides were more favorable than those of the corresponding citrullinated ones, but all measured values were within the micromolar range, indicating that there were no major variations in the thermodynamics of binding due to sequence effects. The kinetic dissociation rates, koff, measured by biolayer interferometry (BLI), were always one‐order of magnitude faster for the citrullinated peptides than for the wild‐type ones. Taken together, all these findings indicate that MDM2 is a substrate for PADI4 and is prone to citrullination in the identified (and specific) positions of its N‐terminal region.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>39840810</pmid><doi>10.1002/pro.70033</doi><tpages>21</tpages><orcidid>https://orcid.org/0000-0001-5702-4538</orcidid><orcidid>https://orcid.org/0000-0002-4933-0428</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0961-8368 |
ispartof | Protein science, 2025-02, Vol.34 (2), p.e70033-n/a |
issn | 0961-8368 1469-896X 1469-896X |
language | eng |
recordid | cdi_proquest_miscellaneous_3158102990 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Binding Calorimetry Circular dichroism Citrullination Citrulline Dichroism Enzymes Fragments Humans Interferometry Isoforms isothermal titration calorimetry MDM2 MDM2 protein molecular docking NMR Nuclear magnetic resonance p53 Protein PADI4 Peptides Peptides - chemistry Peptides - metabolism Polypeptides Protein Binding Protein-arginine deiminase Protein-Arginine Deiminase Type 4 - chemistry Protein-Arginine Deiminase Type 4 - metabolism Protein-Arginine Deiminases - chemistry Protein-Arginine Deiminases - genetics Protein-Arginine Deiminases - metabolism protein–protein interactions Proto-Oncogene Proteins c-mdm2 - chemistry Proto-Oncogene Proteins c-mdm2 - genetics Proto-Oncogene Proteins c-mdm2 - metabolism Residues Titration Titration calorimetry Tumor suppressor genes Ubiquitin-protein ligase |
title | Citrullination at the N‐terminal region of MDM2 by the PADI4 enzyme |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T10%3A38%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Citrullination%20at%20the%20N%E2%80%90terminal%20region%20of%20MDM2%20by%20the%20PADI4%20enzyme&rft.jtitle=Protein%20science&rft.au=Neira,%20Jos%C3%A9%20L.&rft.date=2025-02&rft.volume=34&rft.issue=2&rft.spage=e70033&rft.epage=n/a&rft.pages=e70033-n/a&rft.issn=0961-8368&rft.eissn=1469-896X&rft_id=info:doi/10.1002/pro.70033&rft_dat=%3Cproquest_cross%3E3158102990%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3162097953&rft_id=info:pmid/39840810&rfr_iscdi=true |